Agent for the selective adjustment of blood lipids

摘要

The invention relates to the medicine, namely to an agent for reducing the cholesterol and triglycerides in the blood plasma. The agent claimed comprises a nanocomposite that is a carbon-containing nanoparticles coated with the organic alkyl functional groups representing the residuals —C₄H₉, —C₆H₁₁, —C₈H₁₅, —C₁₀H₂₁, —C₁₆H₃₃, —C₁₈H₃₅. These groups are deposited by the covalent modification using diazonium salts of the general formula XC₆H₄N₂⁺Y⁻, where X is the alkyl residual —C₄H₉, —C₆H₁₁, —C₈H₁₅, —C₁₀H₂₁, —C₁₆H₃₃, or C₁₈H₃₅, Y is the anion HSO₄⁻, Cl⁻, BF₄⁻ or TsO⁻. The invention provides an effective reduction of cholesterol and triglyceride presented in the blood plasma.